ESC 365 - The role of TTR as a surrogate marker in treatment of ATTR-CM

Open Access

The role of TTR as a surrogate marker in treatment of ATTR-CM

Session: What is the role of TTR in transthyretin amyloid cardiomyopathy?

Topic: Cardiomyopathies

Speaker: Doctor J. Gillmore (Greater London, GB)

Sponsored by BridgeBio

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

12 presentations

3 followers

5 more presentations in this session

Introduction

Speaker: Doctor M. Maurer (New York, US)

The role of TTR in ATTR-CM disease and treatment

Speaker: Professor T. Damy (Creteil, FR)

Question & answers

Questions & answers

Summary, audience Q&A, panel discussion and closing of session

Speaker: Doctor M. Maurer (New York, US) Professor T. Damy (Creteil, FR) Doctor J. Gillmore (Greater London, GB)

Access the full session

What is the role of TTR in transthyretin amyloid cardiomyopathy?

Speakers: Doctor J. Gillmore, Doctor M. Maurer, Professor T. Damy, Doctor M. Maurer, Professor T. Damy...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources